Cubist Systematic Strategies’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$2.49M Sell
68,572
-74,185
-52% -$2.52M 0.01% 1427
2025
Q2
$4.48M Buy
142,757
+74,128
+108% +$2.3M 0.02% 1081
2025
Q1
$2.04M Sell
68,629
-37,971
-36% -$1.14M 0.01% 1408
2024
Q4
$3.14M Buy
+106,600
New +$3.37M 0.02% 1094
2024
Q3
Sell
-53,687
Closed -$1.82M 3219
2024
Q2
$1.82M Sell
53,687
-3,943
-7% -$201K 0.01% 1394
2024
Q1
$3.75M Buy
57,630
+38,902
+208% +$2.67M 0.02% 1170
2023
Q4
$1.28M Sell
18,728
-46,907
-71% -$2.44M 0.01% 1854
2023
Q3
$3.41M Buy
65,635
+7,698
+13% +$456K 0.03% 997
2023
Q2
$3.47M Buy
57,937
+36,516
+170% +$2.08M 0.02% 1075
2023
Q1
$1.06M Sell
21,421
-62,562
-74% -$3.52M 0.01% 2142
2022
Q4
$4.79M Buy
83,983
+33,295
+66% +$1.87M 0.03% 1050
2022
Q3
$2.38M Buy
50,688
+8,679
+21% +$414K 0.01% 1826
2022
Q2
$1.57M Buy
42,009
+41,321
+6,006% +$1.34M 0.01% 2081
2022
Q1
$21K Buy
+688
New +$17.4K ﹤0.01% 3473
2021
Q4
Sell
-500
Closed -$19K 3535
2021
Q3
$19K Buy
+500
New +$16.9K ﹤0.01% 2888

Other funds holding IMCR

Cubist Systematic Strategies's IMCR Position: Q3 2025 in Review

Cubist Systematic Strategies reduced its Immunocore (IMCR) stake by 52% in Q3 2025, selling an estimated $2.52M and leaving 68,572 shares worth $2.49M. The position accounts for 0.01% of the portfolio, ranked #1427.

Cubist Systematic Strategies first reported a position in IMCR in Q3 2021 and has held it in 15 quarters since. The position peaked at $4.79M in Q4 2022. 132 funds tracked by Wall St. Rank hold IMCR as of Q3 2025.

  • Cubist Systematic Strategies held 68,572 shares of Immunocore worth $2.49M as of Q3 2025.
  • Cubist Systematic Strategies sold 74,185 Immunocore shares in Q3 2025, an estimated $2.52M.
  • Immunocore made up 0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #1427 holding.
  • Cubist Systematic Strategies first reported a position in Immunocore in Q3 2021 and has held it in 15 quarters since.
  • Cubist Systematic Strategies's Immunocore position peaked at $4.79M in Q4 2022.
  • 132 funds tracked by Wall St. Rank held Immunocore as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.